Tvardi Therapeutics Inc. - TVRD - stock price prediction, stock price target, analyst ratings from 7 analysts

Tvardi Therapeutics Inc. has a share price target of US$ 57, revenue growth forecast of -92.3%, for FY25, based on top 7 analyst calls.